• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Align Technology Inc.

With Wall Street’s attention fixated on the congressional testimony of former Special Counsel Robert Mueller, medical stocks quietly rise from the ashes. Well, mostly.

Steve Walker    August 6, 2019 August 6, 2019    No Comments on With Wall Street’s attention fixated on the congressional testimony of former Special Counsel Robert Mueller, medical stocks quietly rise from the ashes. Well, mostly.

After taking a beating the previous week, medical stocks staged a comeback as attention was focused on the congressional testimony of Robert Mueller. Here are the top three winners and… Read more »

Corporate, Government, Investment, Pharmaceuticals    Achillion Pharmaceuticals Inc., Align Technology Inc., Anika Therapeutics Inc., Harvard Bioscience Inc., Jim Green, Joe Hogan, Neuralstem Inc.

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
  • Health-sector IPO market cools off this week after torrid start to November.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • It’s time to reclassify schizophrenia as a neurologic disorder.
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress